GlaxoSmithKline Pharmaceuticals

BSE : 500660 | NSE : GLAXO

Industry : Pharma MNC | ISIN : INE159A01016 | FreeFloat : 50.00% | FnO : No | LotSize : N/A


Intellectual Capital (IC)12,176.94
Net Worth (NW)2,662.96
Intrinsic Worth (IW)14,839.90
Market Cap (MC)28,238.29
Economic Value Added84.04
Discount Rate%
Liquidity Premium%
Knowledge Basis (IC/IW)82.06%
IC Gross Margin (EBITDA/IC)6.38%
IC Net Margin (NPT/IC)9.25%
Knowledge Turnover (Sales/IC)0.27
Market to Intrinsic Value (MC/IW)1.90

As OfIntrinsic ValueMarket Price
31 Mar 2022Rs. 876.00Rs. 1,666.90
26 May 2022 ---- Rs. 1,511.00
-9.70     -0.64%
Fundamental - medium termTechnical - near termCombined outlook
EVA > 0 : YesBuy10 DMA : Rs. 1,526.15SellAvoid
KB > 50% : Yes50 DMA : Rs. 1,575.44
0 < M2IV < 1 : NoVol-Price trend : Falling

Question 3 - Is this stock undervalued?


Question 2 - Does this business have significant knowledge assets?


Question 1 - Is this business generating enough profits to cover its cost of capital?

* EVA is a registered trademark of Stern Stewart and Co.

Quarterly Results (Rs. Cr)
Quarter
Type*
Sales
Income
EBITDA
EBIT
PBT
PAT
NPT
Jun-19
C
787.97
818.78
165.29
146.23
176.11
113.54
113.54
Sep-19
C
882.02
897.90
194.01
171.31
587.41
502.75
502.75
Dec-19
C
778.59
795.09
124.39
106.06
-634.32
-661.16
-661.16
Mar-20
C
775.80
791.62
200.65
178.06
176.55
138.07
138.60
Jun-20
C
648.59
706.51
171.99
150.22
149.14
110.83
107.80
Sep-20
C
879.32
888.36
149.77
127.81
126.93
76.47
76.47
Dec-20
C
857.20
871.22
230.06
212.35
211.41
156.51
156.51
Mar-21
C
813.75
843.35
81.49
63.64
63.01
14.33
12.40
Jun-21
C
789.99
821.72
183.40
165.69
164.90
121.08
121.08
Sep-21
C
1009.87
1024.84
291.49
273.89
273.54
204.24
204.24
Dec-21
C
815.92
826.24
190.21
172.34
171.76
150.35
150.35
Mar-22
C
809.63
828.39
223.48
208.13
207.85
1219.05
1219.05
* C - Consolidated, S - Standalone